Decera Clinical Education
@deceraclinicaledu.bsky.social
We're becoming Decera Clinical Education! A leader in the development of innovative & interactive #CME/#CE educational programs for healthcare professionals | Clinically relevant, evidence-based. #MedSky #MedicalEducation 👉 https://bit.ly/3XD4G1Z
Pinned
We’re now Decera Clinical Education (deh-SAIR-uh), formerly CCO. Our name has evolved, but our expert-led CME/CE and trusted medical education remain the same. Thank you for celebrating this next chapter with us! Learn more:
Learn more → deceraclinical.com/education/co...
Learn more → deceraclinical.com/education/co...
Therapeutic innovation is reshaping how we treat CKD, heart failure, and metabolic disease—together. 💓🗣️
Experts highlight emerging evidence behind GLP-1–based and dual incretin therapies and their impact on cardiovascular and renal outcomes.
▶️ Watch the full expert video: https://bit.ly/49ZSUEL
Experts highlight emerging evidence behind GLP-1–based and dual incretin therapies and their impact on cardiovascular and renal outcomes.
▶️ Watch the full expert video: https://bit.ly/49ZSUEL
February 18, 2026 at 6:07 PM
Therapeutic innovation is reshaping how we treat CKD, heart failure, and metabolic disease—together. 💓🗣️
Experts highlight emerging evidence behind GLP-1–based and dual incretin therapies and their impact on cardiovascular and renal outcomes.
▶️ Watch the full expert video: https://bit.ly/49ZSUEL
Experts highlight emerging evidence behind GLP-1–based and dual incretin therapies and their impact on cardiovascular and renal outcomes.
▶️ Watch the full expert video: https://bit.ly/49ZSUEL
Expert insights on diagnosing and managing systemic mastocytosis, tailored for dermatology professionals.
✨ Download the slideset for your own practice: https://bit.ly/46nD7hV
#SystemicMastocytosis #DermatologyEducation #ClinicalInsights
✨ Download the slideset for your own practice: https://bit.ly/46nD7hV
#SystemicMastocytosis #DermatologyEducation #ClinicalInsights
Expert Conversations in Systemic Mastocytosis: Clinical Insights for Dermatology Professionals
Expert-curated slides on the dermatologist’s role in diagnosing and managing care for patients with systemic mastocytosis (SM), including the latest advances on treating symptoms and employing targete...
bit.ly
February 11, 2026 at 5:50 PM
Expert insights on diagnosing and managing systemic mastocytosis, tailored for dermatology professionals.
✨ Download the slideset for your own practice: https://bit.ly/46nD7hV
#SystemicMastocytosis #DermatologyEducation #ClinicalInsights
✨ Download the slideset for your own practice: https://bit.ly/46nD7hV
#SystemicMastocytosis #DermatologyEducation #ClinicalInsights
Answer below, then watch the full certified on-demand webcast. An expert shares practical strategies for managing key antibody–drug conjugate toxicities, highlighting supportive care, dose adjustments, and patient education to support adherence and outcomes.
💻 Watch here: https://bit.ly/4akGoRr
💻 Watch here: https://bit.ly/4akGoRr
February 10, 2026 at 5:55 PM
Answer below, then watch the full certified on-demand webcast. An expert shares practical strategies for managing key antibody–drug conjugate toxicities, highlighting supportive care, dose adjustments, and patient education to support adherence and outcomes.
💻 Watch here: https://bit.ly/4akGoRr
💻 Watch here: https://bit.ly/4akGoRr
How are HCPs approaching cognitive care in everyday practice? Decera Clinical learners share real-world insights on what works, what’s missing, and what’s next.
Read the Clinical Thought: https://bit.ly/3NW7Jke
Read the Clinical Thought: https://bit.ly/3NW7Jke
February 6, 2026 at 10:07 PM
How are HCPs approaching cognitive care in everyday practice? Decera Clinical learners share real-world insights on what works, what’s missing, and what’s next.
Read the Clinical Thought: https://bit.ly/3NW7Jke
Read the Clinical Thought: https://bit.ly/3NW7Jke
From scientific discovery to clinical decision-making. Michelle Kittleson, MD, PhD, Katherine Tuttle, MD, & Stefano Del Prato, MD, reflect on how decades of cross-disciplinary research are shaping CKM care.
▶️ Watch full video: https://bit.ly/49ZSUEL
▶️ Watch full video: https://bit.ly/49ZSUEL
February 4, 2026 at 6:13 PM
From scientific discovery to clinical decision-making. Michelle Kittleson, MD, PhD, Katherine Tuttle, MD, & Stefano Del Prato, MD, reflect on how decades of cross-disciplinary research are shaping CKM care.
▶️ Watch full video: https://bit.ly/49ZSUEL
▶️ Watch full video: https://bit.ly/49ZSUEL
Case Challenge: Personalizing Care in HR+/HER2- Metastatic Breast Cancer
▶️ Explore the case and test your clinical approach: https://bit.ly/3Zovtjq
#CME #OncologyEducation
▶️ Explore the case and test your clinical approach: https://bit.ly/3Zovtjq
#CME #OncologyEducation
February 2, 2026 at 8:52 PM
Case Challenge: Personalizing Care in HR+/HER2- Metastatic Breast Cancer
▶️ Explore the case and test your clinical approach: https://bit.ly/3Zovtjq
#CME #OncologyEducation
▶️ Explore the case and test your clinical approach: https://bit.ly/3Zovtjq
#CME #OncologyEducation
Barriers to Optimal Care and Educational Opportunities for European Physicians Treating Relapsed/Refractory (R/R) CLL
📄 Download the free PDF to explore the insights and implications for clinical practice: https://bit.ly/4bKu12k
📄 Download the free PDF to explore the insights and implications for clinical practice: https://bit.ly/4bKu12k
Barriers to Optimal Care and Educational Opportunities for European Physicians Treating Patients With Relapsed/Refractory (R/R) CLL
This poster, presented at the 2025 ASH annual meeting, features data from an online educational program and details educational opportunities for European physicians in treating R/R CLL; variance in how physicians in different European countries manage ...
bit.ly
January 30, 2026 at 10:11 PM
Barriers to Optimal Care and Educational Opportunities for European Physicians Treating Relapsed/Refractory (R/R) CLL
📄 Download the free PDF to explore the insights and implications for clinical practice: https://bit.ly/4bKu12k
📄 Download the free PDF to explore the insights and implications for clinical practice: https://bit.ly/4bKu12k
From conference data to clinical impact. Amir T. Fathi, MD shares key leukemia takeaways from American Society of Hematology 2025, highlighting what new data may mean for patients with AML and CML.
🎧 Listen to the full discussion:https://bit.ly/3NN1bUW
#ASH25 #MedicalEducation
🎧 Listen to the full discussion:https://bit.ly/3NN1bUW
#ASH25 #MedicalEducation
January 23, 2026 at 8:48 PM
From conference data to clinical impact. Amir T. Fathi, MD shares key leukemia takeaways from American Society of Hematology 2025, highlighting what new data may mean for patients with AML and CML.
🎧 Listen to the full discussion:https://bit.ly/3NN1bUW
#ASH25 #MedicalEducation
🎧 Listen to the full discussion:https://bit.ly/3NN1bUW
#ASH25 #MedicalEducation
Real-world MASH care goes beyond initial treatment decisions. This Clinical Thought explores ongoing challenges in long-term MASH management, and how new data and updated guidelines are reshaping sustained success.
👇 Share your answer
📖 Read the full Clinical Thought https://bit.ly/3MLuZB5
👇 Share your answer
📖 Read the full Clinical Thought https://bit.ly/3MLuZB5
January 12, 2026 at 6:14 PM
Real-world MASH care goes beyond initial treatment decisions. This Clinical Thought explores ongoing challenges in long-term MASH management, and how new data and updated guidelines are reshaping sustained success.
👇 Share your answer
📖 Read the full Clinical Thought https://bit.ly/3MLuZB5
👇 Share your answer
📖 Read the full Clinical Thought https://bit.ly/3MLuZB5
Early recognition matters in fibrosing ILDs. Expert faculty break down key risk factors and best practices to support timely diagnosis in real-world care.
💥 Watch Fibrosing ILDs on the Frontlines (on-demand)
💥 Earn CE/CME: https://bit.ly/48M4WCs
💥 Watch Fibrosing ILDs on the Frontlines (on-demand)
💥 Earn CE/CME: https://bit.ly/48M4WCs
January 9, 2026 at 9:15 PM
Early recognition matters in fibrosing ILDs. Expert faculty break down key risk factors and best practices to support timely diagnosis in real-world care.
💥 Watch Fibrosing ILDs on the Frontlines (on-demand)
💥 Earn CE/CME: https://bit.ly/48M4WCs
💥 Watch Fibrosing ILDs on the Frontlines (on-demand)
💥 Earn CE/CME: https://bit.ly/48M4WCs
IV iron during acute infection remains debated.
New real-world evidence suggests IV iron use in patients with iron deficiency anemia and acute infection was associated with improved survival and hemoglobin recovery.
📊 Explore the conference slideset for full details: https://bit.ly/4j0hBVP
New real-world evidence suggests IV iron use in patients with iron deficiency anemia and acute infection was associated with improved survival and hemoglobin recovery.
📊 Explore the conference slideset for full details: https://bit.ly/4j0hBVP
January 8, 2026 at 3:54 PM
IV iron during acute infection remains debated.
New real-world evidence suggests IV iron use in patients with iron deficiency anemia and acute infection was associated with improved survival and hemoglobin recovery.
📊 Explore the conference slideset for full details: https://bit.ly/4j0hBVP
New real-world evidence suggests IV iron use in patients with iron deficiency anemia and acute infection was associated with improved survival and hemoglobin recovery.
📊 Explore the conference slideset for full details: https://bit.ly/4j0hBVP
Join Rachna Shroff, MD, MS, FASCO at an ASCO GI 2026 satellite symposium exploring HER2-positive GI cancers, from molecular testing to targeted therapy across gastric/GEJ, CRC, and biliary tract cancers.
👉 Register: https://bit.ly/48FksQl
#ASCOGI2026 #HER2 #GICancers
👉 Register: https://bit.ly/48FksQl
#ASCOGI2026 #HER2 #GICancers
January 5, 2026 at 5:46 PM
Join Rachna Shroff, MD, MS, FASCO at an ASCO GI 2026 satellite symposium exploring HER2-positive GI cancers, from molecular testing to targeted therapy across gastric/GEJ, CRC, and biliary tract cancers.
👉 Register: https://bit.ly/48FksQl
#ASCOGI2026 #HER2 #GICancers
👉 Register: https://bit.ly/48FksQl
#ASCOGI2026 #HER2 #GICancers
The role of HER2 in advanced bladder cancer is rapidly expanding.
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
January 2, 2026 at 8:51 PM
The role of HER2 in advanced bladder cancer is rapidly expanding.
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
📖 Read the full clinical thought commentary for expert perspectives on testing strategies, treatment sequencing, and future directions in HER2-positive urothelial carcinoma: https://bit.ly/4pIHX11
#HER2 #BladderCancer
AI is helping clinicians interpret more, faster, supporting greater access at the point of care.
New text module! Artificial Intelligence in Cardiovascular Care
👉 Download to access expert insights and earn CE/CME: https://bit.ly/48M3cYC
New text module! Artificial Intelligence in Cardiovascular Care
👉 Download to access expert insights and earn CE/CME: https://bit.ly/48M3cYC
Artificial Intelligence in Cardiovascular Care: Foundations and Best Practices for Improving Patient Outcomes
Five cardiology experts discuss the foundations of artificial intelligence in healthcare and best practices for developing and implementing these technologies to enhance the care of patients with suspected or established cardiovascular disease.
bit.ly
December 30, 2025 at 6:37 PM
AI is helping clinicians interpret more, faster, supporting greater access at the point of care.
New text module! Artificial Intelligence in Cardiovascular Care
👉 Download to access expert insights and earn CE/CME: https://bit.ly/48M3cYC
New text module! Artificial Intelligence in Cardiovascular Care
👉 Download to access expert insights and earn CE/CME: https://bit.ly/48M3cYC
What’s changing in HER2 testing and how it should it guide #GIcancercare in 2026?
Expert faculty break down HER2 testing and targeted therapy across gastric/GEJ, CRC, and BTC at ASCO GI 2026.
📅 Jan 9 | In-person + virtual
👉 https://bit.ly/48FksQl
HER2 #ASCOGI2026
Expert faculty break down HER2 testing and targeted therapy across gastric/GEJ, CRC, and BTC at ASCO GI 2026.
📅 Jan 9 | In-person + virtual
👉 https://bit.ly/48FksQl
HER2 #ASCOGI2026
December 29, 2025 at 5:54 PM
What’s changing in HER2 testing and how it should it guide #GIcancercare in 2026?
Expert faculty break down HER2 testing and targeted therapy across gastric/GEJ, CRC, and BTC at ASCO GI 2026.
📅 Jan 9 | In-person + virtual
👉 https://bit.ly/48FksQl
HER2 #ASCOGI2026
Expert faculty break down HER2 testing and targeted therapy across gastric/GEJ, CRC, and BTC at ASCO GI 2026.
📅 Jan 9 | In-person + virtual
👉 https://bit.ly/48FksQl
HER2 #ASCOGI2026
What stood out in leukemias at #ASH25?
In this PulseCast episode, Amir T. Fathi, MD, reviews key studies and discusses how emerging data may inform care for patients with AML and CML.
Listen to the full episode here: https://bit.ly/4p4m9vM
In this PulseCast episode, Amir T. Fathi, MD, reviews key studies and discusses how emerging data may inform care for patients with AML and CML.
Listen to the full episode here: https://bit.ly/4p4m9vM
December 28, 2025 at 6:18 PM
What stood out in leukemias at #ASH25?
In this PulseCast episode, Amir T. Fathi, MD, reviews key studies and discusses how emerging data may inform care for patients with AML and CML.
Listen to the full episode here: https://bit.ly/4p4m9vM
In this PulseCast episode, Amir T. Fathi, MD, reviews key studies and discusses how emerging data may inform care for patients with AML and CML.
Listen to the full episode here: https://bit.ly/4p4m9vM
New ASH 2025 analysis: CLL17 (Phase III)
Fixed-duration venetoclax + obinutuzumab or venetoclax + ibrutinib showed noninferior PFS vs continuous ibrutinib in untreated CLL.
Slideset 👉 https://bit.ly/3XW6Qdu
#CLL #Hematology
Fixed-duration venetoclax + obinutuzumab or venetoclax + ibrutinib showed noninferior PFS vs continuous ibrutinib in untreated CLL.
Slideset 👉 https://bit.ly/3XW6Qdu
#CLL #Hematology
CLL17: Phase III Trial of Continuous Ibrutinib vs Fixed-Duration Venetoclax Plus Obinutuzumab or Venetoclax Plus Ibrutinib for Untreated CLL
Data from the phase III CLL17 study demonstrate noninferior PFS with fixed-duration venetoclax plus obinutuzumab or venetoclax plus ibrutinib vs continuous ibrutinib among patients with untreated CLL ...
deceraclinical.com
December 26, 2025 at 9:20 PM
New ASH 2025 analysis: CLL17 (Phase III)
Fixed-duration venetoclax + obinutuzumab or venetoclax + ibrutinib showed noninferior PFS vs continuous ibrutinib in untreated CLL.
Slideset 👉 https://bit.ly/3XW6Qdu
#CLL #Hematology
Fixed-duration venetoclax + obinutuzumab or venetoclax + ibrutinib showed noninferior PFS vs continuous ibrutinib in untreated CLL.
Slideset 👉 https://bit.ly/3XW6Qdu
#CLL #Hematology
How can real-world clinician insights improve education design?
This PDF explores a community-informed, multimodal program supporting patient-centered care in myelofibrosis with JAK inhibitors.
📄 https://bit.ly/4qeLy6U
#Myelofibrosis #Hematology #MedicalEducation
This PDF explores a community-informed, multimodal program supporting patient-centered care in myelofibrosis with JAK inhibitors.
📄 https://bit.ly/4qeLy6U
#Myelofibrosis #Hematology #MedicalEducation
December 23, 2025 at 6:17 PM
How can real-world clinician insights improve education design?
This PDF explores a community-informed, multimodal program supporting patient-centered care in myelofibrosis with JAK inhibitors.
📄 https://bit.ly/4qeLy6U
#Myelofibrosis #Hematology #MedicalEducation
This PDF explores a community-informed, multimodal program supporting patient-centered care in myelofibrosis with JAK inhibitors.
📄 https://bit.ly/4qeLy6U
#Myelofibrosis #Hematology #MedicalEducation
Understanding HER2 in NSCLC continues to evolve.
This downloadable slideset reviews:
✔ HER2 biology and relevance in NSCLC
✔ Testing approaches and emerging methodologies
✔ An overview of ADCs and their clinical utility
Access the slides here: https://bit.ly/4rVKypI
#HER2Testing #CME
This downloadable slideset reviews:
✔ HER2 biology and relevance in NSCLC
✔ Testing approaches and emerging methodologies
✔ An overview of ADCs and their clinical utility
Access the slides here: https://bit.ly/4rVKypI
#HER2Testing #CME
HER2 in Context in NSCLC, Testing Strategies and Advances in Methodologies, and a Brief Review of ADCs in NSCLC
Downloadable slides on the role of HER2 in NSCLC, testing strategies and advances in methodologies, and a brief review of the utility of ADCs in NSCLC
deceraclinical.com
December 22, 2025 at 5:46 PM
Understanding HER2 in NSCLC continues to evolve.
This downloadable slideset reviews:
✔ HER2 biology and relevance in NSCLC
✔ Testing approaches and emerging methodologies
✔ An overview of ADCs and their clinical utility
Access the slides here: https://bit.ly/4rVKypI
#HER2Testing #CME
This downloadable slideset reviews:
✔ HER2 biology and relevance in NSCLC
✔ Testing approaches and emerging methodologies
✔ An overview of ADCs and their clinical utility
Access the slides here: https://bit.ly/4rVKypI
#HER2Testing #CME
Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute:. https://bit.ly/3KR5QE1
#MedicalEducation #CME
#MedicalEducation #CME
December 19, 2025 at 8:53 PM
Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute:. https://bit.ly/3KR5QE1
#MedicalEducation #CME
#MedicalEducation #CME
AI is already reshaping cardiovascular care, from imaging reconstruction to diagnostic and monitoring assistance. 💗
When clinicians know how to interpret outputs, AI can support clearer decisions and earlier insights.
👉 Learn more and earn CE/CME: https://bit.ly/48M3cYC
When clinicians know how to interpret outputs, AI can support clearer decisions and earlier insights.
👉 Learn more and earn CE/CME: https://bit.ly/48M3cYC
December 17, 2025 at 3:50 PM
AI is already reshaping cardiovascular care, from imaging reconstruction to diagnostic and monitoring assistance. 💗
When clinicians know how to interpret outputs, AI can support clearer decisions and earlier insights.
👉 Learn more and earn CE/CME: https://bit.ly/48M3cYC
When clinicians know how to interpret outputs, AI can support clearer decisions and earlier insights.
👉 Learn more and earn CE/CME: https://bit.ly/48M3cYC
What a wonderful two days at the 11th Annual Psychopharmacology Update 2025 🧠
Thank you to our expert faculty and all the clinicians who joined us.
Explore event resources and upcoming programs 👉 https://bit.ly/44sEqva
#CME #MedicalEducation #PsychiatricCare
Thank you to our expert faculty and all the clinicians who joined us.
Explore event resources and upcoming programs 👉 https://bit.ly/44sEqva
#CME #MedicalEducation #PsychiatricCare
December 15, 2025 at 8:57 PM
What a wonderful two days at the 11th Annual Psychopharmacology Update 2025 🧠
Thank you to our expert faculty and all the clinicians who joined us.
Explore event resources and upcoming programs 👉 https://bit.ly/44sEqva
#CME #MedicalEducation #PsychiatricCare
Thank you to our expert faculty and all the clinicians who joined us.
Explore event resources and upcoming programs 👉 https://bit.ly/44sEqva
#CME #MedicalEducation #PsychiatricCare
Join Matthew Gubens, MD, MS, FASCO and Estelamari Rodriguez, MD, MPH this Tuesday for a 1-hour expert discussion on the latest insights in HER2-altered NSCLC.
A concise, practical session designed to support real-world decision-making 👉 https://bit.ly/451c6QE
#MedicalEducation #CME #NSCLC #HER2
A concise, practical session designed to support real-world decision-making 👉 https://bit.ly/451c6QE
#MedicalEducation #CME #NSCLC #HER2
December 14, 2025 at 6:20 PM
Join Matthew Gubens, MD, MS, FASCO and Estelamari Rodriguez, MD, MPH this Tuesday for a 1-hour expert discussion on the latest insights in HER2-altered NSCLC.
A concise, practical session designed to support real-world decision-making 👉 https://bit.ly/451c6QE
#MedicalEducation #CME #NSCLC #HER2
A concise, practical session designed to support real-world decision-making 👉 https://bit.ly/451c6QE
#MedicalEducation #CME #NSCLC #HER2
🩺 Words matter in patient care. Just as we say “patients have cancer” rather than “cancer patients,” the same approach should guide conversations around overweight and obesity.
Watch this medical minute: https://bit.ly/3KRmxiM
#MedicalEducation #CME
Watch this medical minute: https://bit.ly/3KRmxiM
#MedicalEducation #CME
December 13, 2025 at 8:54 PM
🩺 Words matter in patient care. Just as we say “patients have cancer” rather than “cancer patients,” the same approach should guide conversations around overweight and obesity.
Watch this medical minute: https://bit.ly/3KRmxiM
#MedicalEducation #CME
Watch this medical minute: https://bit.ly/3KRmxiM
#MedicalEducation #CME
🧠 Improving migraine care through shared learning. In this video, expert faculty reflect on key insights from our ECHO program, where clinical teams collaborated, implemented QI projects, & discussed complex cases to enhance outcomes for patients with migraine. ▶️ Watch: https://bit.ly/48BvrtZ
December 11, 2025 at 3:49 PM
🧠 Improving migraine care through shared learning. In this video, expert faculty reflect on key insights from our ECHO program, where clinical teams collaborated, implemented QI projects, & discussed complex cases to enhance outcomes for patients with migraine. ▶️ Watch: https://bit.ly/48BvrtZ